PH17207A - New imidazo-rifamycin derivatives with antibacterial utility - Google Patents

New imidazo-rifamycin derivatives with antibacterial utility

Info

Publication number
PH17207A
PH17207A PH25656A PH25656A PH17207A PH 17207 A PH17207 A PH 17207A PH 25656 A PH25656 A PH 25656A PH 25656 A PH25656 A PH 25656A PH 17207 A PH17207 A PH 17207A
Authority
PH
Philippines
Prior art keywords
rifamycin derivatives
new imidazo
antibacterial utility
antibacterial
utility
Prior art date
Application number
PH25656A
Other languages
English (en)
Inventor
Egidio Marchi
Lauretta Montecchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of PH17207A publication Critical patent/PH17207A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH25656A 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility PH17207A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (1)

Publication Number Publication Date
PH17207A true PH17207A (en) 1984-06-19

Family

ID=11107198

Family Applications (2)

Application Number Title Priority Date Filing Date
PH25656A PH17207A (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Country Status (25)

Country Link
US (1) US4341785A (oth)
JP (1) JPS5711987A (oth)
AR (1) AR226212A1 (oth)
AT (1) AT373599B (oth)
AU (1) AU537093B2 (oth)
BE (1) BE888895A (oth)
CA (1) CA1142518A (oth)
CH (1) CH648037A5 (oth)
DE (1) DE3120460A1 (oth)
DK (1) DK157876C (oth)
EG (1) EG14891A (oth)
ES (1) ES8203388A1 (oth)
FI (1) FI69467C (oth)
FR (1) FR2482967A1 (oth)
GB (1) GB2079270B (oth)
GR (1) GR75640B (oth)
IE (1) IE51204B1 (oth)
IT (1) IT1154655B (oth)
LU (1) LU83376A1 (oth)
NL (1) NL187022C (oth)
NO (1) NO155622C (oth)
PH (2) PH17207A (oth)
PT (1) PT73064B (oth)
SE (1) SE453089B (oth)
ZA (1) ZA813430B (oth)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
TW534813B (en) * 1997-02-28 2003-06-01 Kaneka Corp Treating agent for diseases due to infection with helicobacter
US7122525B2 (en) * 2001-11-21 2006-10-17 Activbiotics, Inc. Targeted therapeutics and uses thereof
AU2002364162A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
AU2003276254A1 (en) * 2002-11-05 2004-06-07 Piero Chiarelli Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
EP1698630B1 (en) * 2005-03-03 2014-09-03 ALFA WASSERMANN S.p.A. New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0614758A2 (pt) 2005-08-11 2011-04-12 Targanta Therapeutics Inc rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
BRPI0708561A2 (pt) 2006-03-09 2011-06-07 Salix Pharmaceuticals Inc preparação farmacêutica, e métodos de tratamento de um indivìduo que sofre de um distúrbio anal, e de avaliação da eficácia de um tratamento de distúrbio anal em um indivìduo, monitoramento do progresso de um indivìduo sendo tratado para um distúrbio anal, ou um método de seleção de um indivìduo para o tratamento de distúrbio anal
SI2054066T1 (sl) 2006-08-02 2015-08-31 Salix Pharmaceuticals, Inc. Postopki za zdravljenje radiacijskega enteritisa
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
CA2663776C (en) * 2006-09-22 2016-01-26 Cipla Limited Rifaximin in an amorphous form
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
AU2008273699A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
PT2011486E (pt) 2007-07-06 2012-08-24 Lupin Ltd Composições farmacêuticas de rifaximina
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
MY158257A (en) * 2008-02-25 2016-09-30 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
AU2009219240B2 (en) 2008-02-26 2014-10-16 Salix Pharmaceuticals, Ltd. Methods for treating bowel diseases
US20090324736A1 (en) 2008-05-07 2009-12-31 Salix Pharmaceuticals, Ltd. Methods of treating bowel diseases by administering a bowel cleanser and an antibiotic
EP2324041A4 (en) 2008-08-13 2012-06-13 Targanta Therapeutics Corp PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
WO2010035751A1 (ja) 2008-09-26 2010-04-01 あすか製薬株式会社 機能性消化管障害の予防及び／又は治療剤
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
EP4342465A3 (en) 2008-10-02 2024-06-12 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
JP5756020B2 (ja) 2008-12-10 2015-07-29 シプラ・リミテッド リファキシミン複合体
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
AU2010271070A1 (en) 2009-06-02 2012-01-12 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
JP2013504597A (ja) 2009-09-13 2013-02-07 サリックス ファーマスーティカルズ，リミテッド 過敏性腸症候群（ｉｂｓ）の治療方法
KR20190000931A (ko) 2009-10-27 2019-01-03 루핀 리미티드 리팍시민의 고형 분산물
KR20120117788A (ko) 2009-11-23 2012-10-24 시플라 리미티드 국소용 폼 조성물
EP2401282B2 (en) 2009-12-28 2017-01-04 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
AU2011218129A1 (en) 2010-02-18 2012-08-23 Board Of Regents Of The University Of Texas System Methods for treating infection
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CA2800235C (en) 2010-03-10 2018-10-16 Lupin Limited Rifaximin ready-to-use suspension
EA033370B1 (ru) 2010-07-12 2019-10-31 Salix Pharmaceuticals Ltd Составы рифаксимина и их применение
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
BR112013020265A2 (pt) 2011-02-11 2017-07-11 Salix Pharmaceuticals Ltd formas de rifaximina e uso das mesmas
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) * 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
JP2014532723A (ja) 2011-11-02 2014-12-08 サリックス ファーマスーティカルズ，リミテッド 過敏性腸症候群（ｉｂｓ）及び感染症を治療するための方法
AU2013212008A1 (en) 2012-01-25 2014-07-10 Alfa Wassermann S.P.A. Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
JP2016510809A (ja) 2013-03-15 2016-04-11 アルファ ワッセルマン ソシエタ ペル アチオニＡｌｆａ Ｗａｓｓｅｒｍａｎｎ Ｓ．Ｐ．Ａ． 膣感染症の治療に使用するためのリファキシミン
US20160047819A1 (en) 2013-03-15 2016-02-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
KR102190173B1 (ko) 2013-04-12 2020-12-14 알파시그마 에스.피.에이. Ｎｓａｉｄ 투여 및 관련 조성물, 방법 및 시스템
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
EP2927235B1 (en) 2014-03-31 2017-02-08 Euticals S.P.A. Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
WO2015159275A2 (en) * 2014-04-19 2015-10-22 Granules India Limited An improved process for the preparation of rifamycin derivatives
CN106795192B (zh) 2014-05-04 2020-06-16 萨利克斯药品公司 Ibs微生物群及其用途
EP3546464B1 (en) * 2014-05-12 2020-06-17 Alfasigma S.p.A. Preparation and use of crystalline form tau of rifaximin solvated with degme
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
CA3038312A1 (en) 2016-09-30 2018-04-05 Salix Pharmaceuticals, Inc. Solid dispersion forms of rifaximin
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
HUE054832T2 (hu) * 2017-06-26 2021-10-28 Biofer Spa Pirido-imidazo rifamicinszármazékok baktériumellenes szerként

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (oth) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
AU7065581A (en) 1981-11-26
NL187022B (nl) 1990-12-03
PH18704A (en) 1985-09-05
ES502906A0 (es) 1982-04-01
GB2079270B (en) 1984-01-18
IT1154655B (it) 1987-01-21
ES8203388A1 (es) 1982-04-01
DK224781A (da) 1981-11-23
GB2079270A (en) 1982-01-20
GR75640B (oth) 1984-08-02
CH648037A5 (de) 1985-02-28
DK157876B (da) 1990-02-26
NO811731L (no) 1981-11-23
DE3120460A1 (de) 1982-03-11
FI811565L (fi) 1981-11-23
IT8003429A0 (it) 1980-05-22
LU83376A1 (fr) 1981-09-11
FR2482967A1 (fr) 1981-11-27
DE3120460C2 (oth) 1990-12-13
FI69467C (fi) 1986-02-10
NL187022C (nl) 1991-05-01
JPS5711987A (en) 1982-01-21
AU537093B2 (en) 1984-06-07
NO155622C (no) 1987-04-29
FR2482967B1 (oth) 1985-03-29
AR226212A1 (es) 1982-06-15
NL8102290A (nl) 1981-12-16
JPS6123192B2 (oth) 1986-06-04
IE51204B1 (en) 1986-10-29
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
SE453089B (sv) 1988-01-11
IE811139L (en) 1981-11-22
PT73064A (en) 1981-06-01
BE888895A (fr) 1981-09-16
NO155622B (no) 1987-01-19
ATA222781A (de) 1983-06-15
FI69467B (fi) 1985-10-31
CA1142518A (en) 1983-03-08
EG14891A (en) 1985-12-31
AT373599B (de) 1984-02-10
DK157876C (da) 1990-07-30
ZA813430B (en) 1982-06-30
US4341785A (en) 1982-07-27

Similar Documents

Publication Publication Date Title
PT73064A (en) New imidazo-rifamycin derivatives with antibacterial utility
JPS5625110A (en) Antibacterial
JPS56157071A (en) Photocell with wide area
JPS56156231A (en) Antibacterial composition
GB2067989B (en) Bis-moranoline derivatives
JPS5640236A (en) Reembedding siliconnwafer groove
GB8324990D0 (en) 3-aminopropoxyphenyl derivatives
EP0054756A3 (en) Antibacterial benzylpyrimidines
GB2088379B (en) 1-phenethylimidazole derivatives
ZA81432B (en) Thiophene derivatives
GB2052621B (en) Door-closer with detent means
AU526593B2 (en) Tetrahydropyranyl derivatives with antibacterial property
NZ190675A (en) Furonaphthyridines with antibacterial properties
GB2070589B (en) 7a1methoxycephalospin derivatives
GB2076395B (en) Nonaprenylamine derivatives
GB2039316B (en) Glazing
JPS5686168A (en) Antibacterial
JPS5652801A (en) Daylight utility illuminator
GB2055942B (en) Double glazing
JPS5732220A (en) Antibacterial
JPS5663349A (en) Turbineehandpiece with lighting
ZA814584B (en) Compounds with antibiotic activity
CA47569S (en) Utility building
BG31418A1 (en) Impactresistant poljsterene composition with diminvated combustibilitj
PH14854A (en) Utility cart